Abstract:Acute respiratory distress syndrome is an unfortunate occurrence and once diagnosed, outlook is bleak with survival rates of approximately 60%. As such, it is of great interest to determine the standard of care and possible novel treatments for the future. Novel treatments of interest include mesenchymal stem cells, ghrelin and high-frequency ventilation. In a phase 1 clinical trial, mesenchymal stem cells have shown great promise in efficacy while being welltolerated in patients. In addition, while ghrelin ha… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.